— Know what they know.
Not Investment Advice

ACOU.ST STO

AcouSort AB
1W: +25.6% 1M: +11.9% 3M: -7.7% YTD: +39.3% 1Y: +11.9% 3Y: -78.8% 5Y: -85.6%
kr 3.58 ($0.36)
+1.13 (+46.12%)
 
Weekly Expected Move ±25.1%
kr 2 kr 3 kr 4 kr 4 kr 5
STO · Healthcare · Medical - Distribution · Tech Score Neutral · Power 47 · kr 75.8M mcap · 7M float · 0.326% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Capkr 75.8M ($7.5M)
52W Range2.03-5.16
Volume273,479
Avg Volume24,418
Beta0.10
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTorsten Freltoft
Employees11
SectorHealthcare
IndustryMedical - Distribution
IPO Date2020-12-14
Building 406
Lund, SN 223 81
SE
46 45 20 45 08 54
About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy and other elements of the future automated systems. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms